Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Spirometry, a type of pulmonary ... lungs to fully expand. This includes obesity, scoliosis (abnormal curvature of the spine), diaphragmatic paralysis, and pleural effusion. Intra-thoracic restriction ...

PULMONARY alveolar microlithiasis is a rare and extraordinary disease in which microscopic stones are found within the pulmonary alveoli. The lungs ... to be diffuse fibrosis or hemosiderosis ...

When I was diagnosed with pulmonary hypertension (PH ... I’d feel like I couldn’t get enough air into my lungs even though I wasn’t exerting myself. I went to the ER and to my doctor ...

Lung inflammation and injury remain a major focus of research ... capillary endocytic and trafficking events in the pathogenesis and potential therapy of pulmonary inflammation and injury. Further ...

Emily Pink, 21, has cystic fibrosis, a rare genetic disorder that causes a build-up of sticky mucus in her lungs and digestive system. She remembers a childhood filled with hospital stays brought ...

Miliary infections, being hematogenous, have a random distribution but tend to involve mainly the lower lung zones ... 2-19–2-23). Fibrosis can usually be recognized on HRCT by the presence ...